Outstanding clinical results reported at 2015 Transcatheter Therapeutics Conference in San Francisco. Baltimore, MD, Oct. 15, 2015 – Harpoon Medical, Inc. a medical device company
By Zach Kaufman, Medgadget The device, produced by Baltimore-based Harpoon Medical, seeks to provide another in a series of recent improvements in mitral valve repair
Edinburgh, United Kingdom, 16th September, 2015 – Edinburgh Molecular Imaging Ltd. (EM Imaging) has signed an exclusive global license for a novel optical imaging agent that could
The company has also received $1.4M of a $2M bridge round to accelerate its clinical program Baltimore, MD, Sept. 15, 2015 – Harpoon Medical, a
Edinburgh, United Kingdom, 2nd September 2015 – The Board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans
Crestwood, KY – July 15, 2015 – Apellis Pharmaceuticals, Inc., a clinical stage complement immunotherapy company, announced today the formation of a Scientific Advisory Board
Brighton, Sussex, May 20th 2015 – Enterprise Therapeutics Ltd, a drug discovery company focused on new therapeutics for respiratory diseases, today announced that it has
Baltimore, MD, May 7, 2015 – Harpoon Medical, a medical device company focused on minimally invasive mitral valve repair, announced today that it has enrolled the
Glasgow, United Kingdom, April 13th 2015 – Clyde Biosciences Ltd. (Clyde Biosciences) has announced a £2 million ‘Series A’ investment led by Epidarex Capital, a
Apellis’ CEO, Cedric Francois, outlines the company thoughts regarding the emergence of immunotherapy as a therapeutic approach that focuses on correcting the underlying immune dysregulation rather